TRIALS

Mucopolysaccharidoses are rare genetic diseases that belong to the group of lysosomal storage diseases. There are six main types of MPS:
What all MPS diseases have in common is that a metabolic enzyme is not present or is insufficiently present. This leads to the deposition of glycosaminoglycans (GAG) in the lysosomes. The consequences are cell damage and functional restrictions of important organs as well as the excretion of GAG in the urine. In most cases the newborn MPS patients are still inconspicuous and only develop symptoms in the course of the first months of life.These are often unspecific in the first place
– but in their combination, they give an important indication of the disease.

NEWS

> Charitable access program
> International MPS day
> International MPS and related diseases symposium
MPS Europe gGmbH
 
Herstallstraße 35
63739 Aschaffenburg
Tel.: +49 6021 - 4381038
Fax: +49 6021 - 858372
www.mps-europe.org
office@mps-europe.org
 
Geschäftsführer: Marija Joldic, Carmen R. Kunkel
Vorsitzender des Beirats : Dr. Alfred Wiesbauer
 
Amtsgericht Aschaffenburg
HRB 14596
 
USt -ID-Nr.: N/A • Bank für Sozialwirtschaft
IBAN DE10 7002 0500 0001 5889 00
BIC: BFSWDE33MUE

Privacy Policy text goes here

GDPR text goes here